INLIF Limited·Industrials
INLIF Limited engages in researching, developing, manufacturing, and selling injection molding machine-dedicated manipulator arms under the iNLIF brand name in the People's Republic of China. The company offers transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms, as well as manipulator arms accessories, including conveyor belts, welded bases, and reducer mounting plates. It also provides installation services for manipulator arms. The company was founded in 2016 and is based in Quanzhou, The People's Republic of China.
Industrials
Industrial - Machinery
124
2025-01-02
3.44
Market Peers







Sanuwave Health (NASDAQ: SNWV - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership. Insider and Institutional Ownership 42.5% of Sanuwave Health

QUANZHOU, China, March 31, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that its Board of Directors has approved a 1-for-16 share combination of all its authorized and issued ordinary shares, including both Class A ordinary shares and Class B ordinary shares (the “Share Combination”), pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 9, 2026 (the “EGM”).

QUANZHOU, China, March 6, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced its financial results for fiscal year 2025 ended December 31, 2025. Mr. Rongjun Xu, Chief Executive Officer of INLIF, remarked, "Fiscal year 2025 marked a pivotal period of transformative momentum for our growth trajectory.